HTR1A and depressive symptom measurement: Chronic depression treatment with these drugs promotes desensitization of 5-HT1A autoreceptors, preventing them from playing their regulatory role in the serotonergic activity and resulting in anxious behavior induced by neuronal hyperactivity, since 5-HT1A would not be activated to promote hyperpolarization [29].